Methylation-specific PCR (MSP) analysis showed that CHD5 was frequently methylated in RCC, prostate and bladder tumor cell lines, which was negatively correlated with the corresponding expression levels (Figure 1C, Supplementary Figure 1A). Here, CHD5 is linked to renal cell carcinoma.